USING CYTOMEGALOVIRUS TO MODULATE TUMOR-ASSOCIATED MACROPHAGES AND DRIVE ANTITUMOR IMMUNE RESPONSES. NEW AWARD.

Thomas Jefferson University, Philadelphia PA

Investigators